Background: Glutamate transporters located in the plasma membrane of cerebr
al astrocytes take up excitatory neurotransmitters from the synaptic cleft.
In diseases characterized by oxidative stress, the extracellular glutamate
concentration increases and contributes to neuronal death. The authors wan
ted to determine whether propofol defends brain cells against oxidant-induc
ed changes in their transport of glutamate.
Methods: Primary cultures of rat cerebral astrocytes were exposed to tert-b
utyl hydroperoxide (1 mM) to serve as an in vitro model of oxidative stress
. Astrocytes were incubated with propofol for 2 h and tert-butyl hydroperox
ide was added for the final hour. Alternatively, astrocytes were incubated
with tert-butyl hydroperoxide for 30 min and then with propofol for another
30 mini, Control cells received drug vehicle rather than propofol. The rat
e of uptake of glutamate, the efflux of the nonmetabolizable analog D-aspar
tate, and the intracellular concentration of the endogenous antioxidant glu
tathione were measured.
Results: Tert-butyl hydroperoxide decreased the glutathione concentration a
nd inhibited glutamate uptake but had a negligible effect on D-aspartate ef
flux. At clinically relevant concentrations. propofol did not affect the gl
utathione concentration bur did prevent the effect of tert-butyl hydroperox
ide on glutamate transport. Furthermore, the addition of propofol after ter
t-butyl hydroperoxide reversed the inhibition of glutamate uptake.
Conclusions: Propofol prevents and reverses the inhibition of excitatory am
ino acid uptake in astrocytes exposed to tert-butyl hydroperoxide, The abil
ity of propofol to defend against peroxide-induced Inhibition of glutamate
clearance riley prevent the pathologic increase in extracellular glutamate
at synapses, and thus delay or pre-vent the onset of excitotoxic neuronal d
eath.